Source Name	Characteristics[organism]	Characteristics[organism part]	Characteristics[developmental stage]	Characteristics[disease]	Characteristics[ancestry category]	Characteristics[age]	Characteristics[sex]	Characteristics[treatment]	Characteristics[cell type]	Characteristics[cell line]	Characteristics[biological replicate]	Characteristics[synthetic peptide]	Material Type	assay name	Technology Type	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[fractionation method]	comment[label]	comment[cleavage agent details]	comment[ms2 mass analyzer]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[cell line]	factor value[treatment]
Sample 1	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	53Y	male	IFNy	not available	12T	1	not synthetic	cell	run 1	proteomic profiling by mass spectrometry	12T_IFN1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/12T_IFN1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	12T	IFNy
Sample 2	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	53Y	male	IFNy	not available	12T	2	not synthetic	cell	run 2	proteomic profiling by mass spectrometry	12T_IFN2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/12T_IFN2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	12T	IFNy
Sample 3	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	53Y	male	IFNy	not available	12T	3	not synthetic	cell	run 3	proteomic profiling by mass spectrometry	12T_IFN3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/12T_IFN3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	12T	IFNy
Sample 4	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	53Y	male	control	not available	12T	1	not synthetic	cell	run 4	proteomic profiling by mass spectrometry	12T_NT1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/12T_NT1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	12T	control
Sample 5	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	53Y	male	control	not available	12T	2	not synthetic	cell	run 5	proteomic profiling by mass spectrometry	12T_NT2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/12T_NT2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	12T	control
Sample 6	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	53Y	male	control	not available	12T	3	not synthetic	cell	run 6	proteomic profiling by mass spectrometry	12T_NT3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/12T_NT3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	12T	control
Sample 7	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	53Y	male	vector control	not available	12T	1	not synthetic	cell	run 7	proteomic profiling by mass spectrometry	12T_EV1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/12T_EV1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	12T	vector control
Sample 8	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	53Y	male	vector control	not available	12T	2	not synthetic	cell	run 8	proteomic profiling by mass spectrometry	12T_EV2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/12T_EV2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	12T	vector control
Sample 9	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	53Y	male	vector control	not available	12T	3	not synthetic	cell	run 9	proteomic profiling by mass spectrometry	12T_EV3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/12T_EV3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	12T	vector control
Sample 10	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	53Y	male	overexpressed both PSMB8 and PSMB9	not available	12T	1	not synthetic	cell	run 10	proteomic profiling by mass spectrometry	12T_OE1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/12T_OE1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	12T	overexpressed both PSMB8 and PSMB9
Sample 11	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	53Y	male	overexpressed both PSMB8 and PSMB10	not available	12T	2	not synthetic	cell	run 11	proteomic profiling by mass spectrometry	12T_OE2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/12T_OE2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	12T	overexpressed both PSMB8 and PSMB10
Sample 12	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	53Y	male	overexpressed both PSMB8 and PSMB11	not available	12T	3	not synthetic	cell	run 12	proteomic profiling by mass spectrometry	12T_OE3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/12T_OE3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	12T	overexpressed both PSMB8 and PSMB11
Sample 13	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	25Y	female	IFNy	not available	108T	1	not synthetic	cell	run 13	proteomic profiling by mass spectrometry	108T_IFN1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/108T_IFN1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	108T	IFNy
Sample 14	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	25Y	female	IFNy	not available	108T	2	not synthetic	cell	run 14	proteomic profiling by mass spectrometry	108T_IFN2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/108T_IFN2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	108T	IFNy
Sample 15	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	25Y	female	IFNy	not available	108T	3	not synthetic	cell	run 15	proteomic profiling by mass spectrometry	108T_IFN3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/108T_IFN3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	108T	IFNy
Sample 16	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	25Y	female	control	not available	108T	1	not synthetic	cell	run 16	proteomic profiling by mass spectrometry	108T_NT1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/108T_NT1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	108T	control
Sample 17	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	25Y	female	control	not available	108T	2	not synthetic	cell	run 17	proteomic profiling by mass spectrometry	108T_NT2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/108T_NT2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	108T	control
Sample 18	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	25Y	female	control	not available	108T	3	not synthetic	cell	run 18	proteomic profiling by mass spectrometry	108T_NT3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/108T_NT3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	108T	control
Sample 19	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	25Y	female	vector control	not available	108T	1	not synthetic	cell	run 19	proteomic profiling by mass spectrometry	108T_EV1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/108T_EV1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	108T	vector control
Sample 20	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	25Y	female	vector control	not available	108T	2	not synthetic	cell	run 20	proteomic profiling by mass spectrometry	108T_EV2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/108T_EV2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	108T	vector control
Sample 21	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	25Y	female	vector control	not available	108T	3	not synthetic	cell	run 21	proteomic profiling by mass spectrometry	108T_EV3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/108T_EV3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	108T	vector control
Sample 22	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	25Y	female	overexpressed both PSMB8 and PSMB9	not available	108T	1	not synthetic	cell	run 22	proteomic profiling by mass spectrometry	108T_OE1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/108T_OE1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	108T	overexpressed both PSMB8 and PSMB9
Sample 23	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	25Y	female	overexpressed both PSMB8 and PSMB10	not available	108T	2	not synthetic	cell	run 23	proteomic profiling by mass spectrometry	108T_OE2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/108T_OE2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	108T	overexpressed both PSMB8 and PSMB10
Sample 24	Homo sapiens	not applicable	not available	metastatic melanoma tumor	not available	25Y	female	overexpressed both PSMB8 and PSMB11	not available	108T	3	not synthetic	cell	run 24	proteomic profiling by mass spectrometry	108T_OE3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/108T_OE3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	108T	overexpressed both PSMB8 and PSMB11
Sample 25	Homo sapiens	not applicable	not available	malignant melanoma	not available	54Y	female	vector control	not available	A375	1	not synthetic	cell	run 25	proteomic profiling by mass spectrometry	A375_EV1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/A375_EV1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	A375	vector control
Sample 26	Homo sapiens	not applicable	not available	malignant melanoma	not available	54Y	female	vector control	not available	A375	2	not synthetic	cell	run 26	proteomic profiling by mass spectrometry	A375_EV2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/A375_EV2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	A375	vector control
Sample 27	Homo sapiens	not applicable	not available	malignant melanoma	not available	54Y	female	vector control	not available	A375	3	not synthetic	cell	run 27	proteomic profiling by mass spectrometry	A375_EV3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/A375_EV3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	A375	vector control
Sample 28	Homo sapiens	not applicable	not available	malignant melanoma	not available	54Y	female	overexpressed both PSMB8 and PSMB9	not available	A375	1	not synthetic	cell	run 28	proteomic profiling by mass spectrometry	A375_OE1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/A375_OE1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	A375	overexpressed both PSMB8 and PSMB9
Sample 29	Homo sapiens	not applicable	not available	malignant melanoma	not available	54Y	female	overexpressed both PSMB8 and PSMB10	not available	A375	2	not synthetic	cell	run 29	proteomic profiling by mass spectrometry	A375_OE2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/A375_OE2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	A375	overexpressed both PSMB8 and PSMB10
Sample 30	Homo sapiens	not applicable	not available	malignant melanoma	not available	54Y	female	overexpressed both PSMB8 and PSMB11	not available	A375	3	not synthetic	cell	run 30	proteomic profiling by mass spectrometry	A375_OE3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD015957/A375_OE3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	not available	NT= Q Exactive Plus;AC=MS:1002634	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	25% NCE	not available	not available	A375	overexpressed both PSMB8 and PSMB11
